Benign Prostatic Hyperplasia Clinical Trials

68 recruitingLast updated: June 17, 2026

There are 68 actively recruiting benign prostatic hyperplasia clinical trials across 33 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 4. Top locations include Beijing, Beijing Municipality, China, Las Vegas, Nevada, United States, Austin, Texas, United States. Updated daily from ClinicalTrials.gov.


Benign Prostatic Hyperplasia Trials at a Glance

68 actively recruiting trials for benign prostatic hyperplasia are listed on ClinicalTrialsFinder across 6 cities in 33 countries. The largest study group is Not Applicable with 44 trials, with the heaviest enrollment activity in Beijing, Las Vegas, and Austin. Lead sponsors running benign prostatic hyperplasia studies include Beni-Suef University, Beth Israel Deaconess Medical Center, and Centre hospitalier de l'Université de Montréal (CHUM).

Browse benign prostatic hyperplasia trials by phase

Treatments under study

About Benign Prostatic Hyperplasia Clinical Trials

Looking for clinical trials for Benign Prostatic Hyperplasia? There are currently 48 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Benign Prostatic Hyperplasia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Benign Prostatic Hyperplasia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 68 trials

Recruiting
Not Applicable

Spinal Versus General Anesthesia in Open Simple Prostatectomy

AnesthesiaUrologic NeoplasmsBenign Prostatic Hyperplasia
Hitit University80 enrolled2 locationsNCT07643415
Recruiting
Not Applicable

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

Prostate CancerProstatectomyBenign Prostatic Hyperplasia+3 more
Axonics, Inc.150 enrolled20 locationsNCT06511141
Recruiting
Not Applicable

Water Vapor Thermal Therapy Versus Ejaculation-Sparing Bipolar Transurethral Enucleation for Benign Prostatic Hyperplasia

Benign Prostatic HyperplasiaLower Urinary Tract SymptomsEjaculatory Dysfunction
Beni-Suef University120 enrolled1 locationNCT07648888
Recruiting
Phase 1

Bioequivalence Study of AJU-G721 and G721R in Healthy Adult Volunteers Under Fasting Conditions

Moderate-to-severe Benign Prostatic Hyperplasia (BPH)
AJU Pharm Co., Ltd.44 enrolled1 locationNCT07643220
Recruiting
Not Applicable

A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men With Benign Prostatic Hyperplasia Symptoms

Benign Prostatic Hyperplasia
Rivermark Medical215 enrolled20 locationsNCT06849258
Recruiting
Not Applicable

Moses 2.0 vs Magneto for HoLEP - a Randomized Controlled Trial

Benign Prostatic HyperplasiaEnlarged Prostate (BPH)
Northwestern University180 enrolled1 locationNCT07632742
Recruiting
Not Applicable

A Prospective Comparative Study Evaluating the Safety and Efficacy of Transurethral Thulium Fiber Laser, Holmium Laser and Bipolar Enucleation of Large Sized Prostate

Bladder Outlet ObstructionLower Urinary Tract SymptomBenign Prostatic Hyperplasia (BPH)
Tanta University90 enrolled1 locationNCT07627178
Recruiting
Not Applicable

Ejaculation-Preserving Versus Standard Bipolar TUEP for BPH

Benign Prostatic HyperplasiaLower Urinary Tract SymptomsBenign Prostatic Obstruction
Beni-Suef University60 enrolled1 locationNCT07629479
Recruiting
Not Applicable

A Single-center, Single-arm Study to Evaluate the Safety and Efficacy of Ultra-minimally Invasive Prostate Dilation in Treating Patients With Significant Obstructive Symptoms Caused by Benign Prostatic Hyperplasia

BPH (Benign Prostatic Hyperplasia)
Qing Yuan5 enrolled1 locationNCT07583706
Recruiting
Not Applicable

Post-Market Study to Assess iTind Safety in Comparison to UroLift

Benign Prostatic Hyperplasia (BPH)
Olympus Corporation of the Americas206 enrolled19 locationsNCT04757116
Recruiting
Not Applicable

HoLEP-ThuLEP - Comparing Lasers for BPH Surgery

BPH (Benign Prostatic Hyperplasia)
Ludwig-Maximilians - University of Munich150 enrolled1 locationNCT07565961
Recruiting
Not Applicable

Thulium Laser Enucleation With Bladder Neck Incision for Small-Volume Benign Prostatic Hyperplasia

Benign Prostatic HyperplasiaLower Urinary Tract Symptoms (LUTS)Bladder Outlet Obstruction
Chinese PLA General Hospital426 enrolled1 locationNCT07569874
Recruiting

BPH Global Registry

Benign Prostatic HyperplasiaLower Urinary Tract Symptoms
Société Internationale d'Urologie7,500 enrolled26 locationsNCT05543200
Recruiting
Not Applicable

Ambulatory Long Length URodynamics Evaluation

Benign Prostatic HyperplasiaUrodynamicsUrinary Bladder, Overactive+4 more
Bright Uro101 enrolled7 locationsNCT07425015
Recruiting
Not Applicable

The Edison System for Treatment of Benign Prostatic Hyperplasia (BPH) Using Histotripsy

Benign Prostatic Hyperplasia
HistoSonics, Inc.80 enrolled1 locationNCT07214675
Recruiting
Not Applicable

Comparison of Functional Outcomes of Ejaculation-preserving Partial Trans Urethral Resection of the Prostate With Complete Trans Urethral Resection of the Prostate for Benign Prostatic Obstruction

Benign Prostatic Hyperplasia
University Hospital, Bordeaux336 enrolled17 locationsNCT05574244
Recruiting

OPtilume™ BPH Catheter SystEm for Treatment of Men eXperiencing Symptomatic BPH

Benign Prostatic Hyperplasia
Urotronic Inc.500 enrolled9 locationsNCT06560476
Recruiting
Phase 2

New Treatment Strategies and Epigenetic Biomarker for Management of Benign Prostatic Hyperplasia

Lower Urinary Track SymptomsBPH (Benign Prostatic Hyperplasia)
Beth Israel Deaconess Medical Center242 enrolled1 locationNCT06944145
Recruiting
Not Applicable

A Prospective, Multicenter, Open-label Study of the Beacon Platform for Holmium Laser Enucleation of the Prostate (HoLEP)

Benign Prostatic Hyperplasia
Andromeda Surgical54 enrolled3 locationsNCT06668142
Recruiting
Not Applicable

Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP)

Benign Prostatic HyperplasiaAnticoagulant Adverse Reaction
Clinique Pasteur389 enrolled1 locationNCT03297281